Huselton, E., Rettig, M. P., Fletcher, T., Ritchey, J., Gehrs, L., McFarland, K., Christ, S., Eades, W. C., Trinkaus, K., Romee, R., Kulkarni, S., Ghobadi, A., Abboud, C., Cashen, A. F., Stockerl-Goldstein, K., Uy, G. L., Vij, R., Westervelt, P., DiPersio, J. F., & Schroeder, M. A. (2021). a phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Leukemia & lymphoma, 62(6), 1441–1449. http://access.bl.uk/ark:/81055/vdc_100131067855.0x000039